Article 79 of Regulation (EU) 2024/1689 — National procedure for AI systems presenting a risk. Official text, practical interpretation, key obligations and compliance implications.

Article 79 is the emergency lane of national market surveillance: what happens when an AI system on the market presents a risk to health, safety or fundamental rights. It choreographs evaluation, corrective action and, if needed, national measures — with Union-wide notification built in.

Official Text Summary

Where a market surveillance authority has sufficient reason to consider that an AI system presents a risk to the health or safety or to the fundamental rights of persons, it carries out an evaluation of the system's compliance with the Regulation — with particular attention where the risk concerns fundamental rights, in cooperation with the authorities referred to in Article 77. Where non-compliance is found, the authority requires the relevant operator to take all appropriate corrective action — bringing the system into compliance, withdrawing it or recalling it — within a period it prescribes. Where the operator fails to act, or the non-compliance is not confined to the national territory, the authority takes appropriate provisional measures to prohibit or restrict the system's availability, and informs the Commission and the other Member States without delay; the Article 81 Union safeguard procedure can follow.

Key Obligations

Compliance Timeline

Applies from 2 August 2026; the 2026 Digital Omnibus deferred the substantive high-risk obligations (Annex III to 2 December 2027, Annex I to 2 August 2028) but did not move this provision.

Official AI Act Compliance Deadline Calendar

Updated · Sources: Regulation (EU) 2024/1689 and the 2026 Digital Omnibus on AI.

Obligation Applies to Original date New date Status Countdown Legal basis
Prohibited Practices (Art. 5) All providers and deployers active AI Act Art. 5
GPAI Rules (Chapter 5) GPAI model providers active AI Act Art. 51-56
Commission Enforcement Powers over GPAI GPAI model providers active AI Act Art. 88-94, 101
Transparency Obligations (Art. 50) Providers and deployers of chatbots, generative, emotion recognition systems active AI Act Art. 50
New Art. 5 Prohibition (CSAM / non-consensual intimate imagery) Providers and deployers of generative AI systems active AI Omnibus 2026 Art. 5
AI-Generated Content Marking (pre-existing systems) Providers of generative AI systems on the market before 2 Aug 2026 active AI Act Art. 50(2) — transitional
Regulatory Sandboxes National competent authorities deferred AI Omnibus 2026 Art. 57
High-risk AI — Annex III (standalone) Providers of standalone Annex III systems deferred AI Omnibus 2026 Art. 6(2)
High-risk AI — Annex I (embedded) AI embedded in Annex I regulated products deferred AI Omnibus 2026 Art. 6(1)

Download JSON · CC BY 4.0

Frequently Asked Questions

The market surveillance authority itself, on sufficient grounds — but a referral from a fundamental-rights authority under Article 77, a complaint under Article 85, or intelligence from another Member State can all supply those grounds.

National measures must be notified to the Commission and the other Member States. If objections are raised, the Union safeguard procedure of Article 81 decides whether the national measure is justified — keeping a single market outcome rather than 27 divergent ones.

Stay ahead of AI Act changes

Get compliance alerts when deadlines or obligations change.

No spam. One-click unsubscribe.

Take compliance further with the AI Act Academy

Templates, training modules, and live Q&A — everything needed to implement AI Act compliance.